Skip to main content
. 2014 Dec 2;112(2):271–277. doi: 10.1038/bjc.2014.597

Table 2. Overall incidence (% per year) of each of the investigative criteria in cases and controls.

Investigative criteria
Cases
Controls
 
 
Lung cancer Stage I (N=31) Stage II (N=17) Stage III (N=31) Stage IV (N=55) Missing/Unknown (N=113) Stage I (N=155) Stage II (N=85) Stage III (N=155) Stage IV (N=275) Missing/Unknown (N=565) Over all cases (N=247) Over all controls (N=1235)
Two different symptoms in 3 months
55.0
65.3
60.0
60.0
70.8
15.8
14.1
11.3
10.9
12.8
64.7
12.7
Cough
56.4
62.4
63.2
69.0
66.4
26.4
22.4
25.8
22.7
22.9
65.0
23.6
Any symptoms
132.2
117.8
114.6
127.2
135.0
52.6
44.7
48.1
42.4
47.6
129.2
46.9
Any two symptoms in 3 months
68.0
77.1
74.4
75.5
85.9
22.3
19.4
17.1
15.1
18.1
79.3
17.9
Chest pain 24.5 39.4 23.2 32.8 33.2 8.1 7.6 7.7 5.8 9.8 31.2 8.3
Investigative criteria
Cases
Controls
 
 
Colorectal cancer Duke's A (N=46) Duke's B (N=125) Duke's C (N=100) Duke's D (N=35) Missing/Unknown (N=43) Duke's A (N=230) Duke's B (N=624) Duke's C (N=500) Duke's D (N=175) Missing/ Unknown (N=215) Over all cases (N=349) Over all controls (N=1744)
Any symptoms
87.0
85.2
80.0
95.7
79.1
19.1
18.2
17.9
20.6
18.1
84.3
18.5
Rectal bleeding
45.9
26.0
25.2
23.7
32.1
2.0
2.1
3.0
2.3
2.6
28.9
2.4
Any two symptoms in 6 months
47.9
46.4
43.6
57.4
44.5
5.0
6.3
6.3
6.3
8.4
46.7
6.4
Two different symptoms in 6 months
33.8
33.6
30.6
42.0
34.3
2.6
3.9
4.5
3.4
5.3
33.7
4.0
Abdominal pain 29.7 35.2 31.0 44.7 29.2 6.1 5.4 6.6 7.7 6.5 33.5 6.2